fusidic acid has been researched along with Rhabdomyolysis in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deljehier, T; Haramburu, F; Miremont-Salamé, G; Nguyen, L; Pariente, A; Rigothier, C; Rubin, S; Théophile, H | 1 |
| Cowan, R; Grayson, ML; Johnson, PD; Urbancic, K | 1 |
| Bachoumas, K; Fiancette, M; Lacherade, JC; Lascarrou, JB; Leclair, F; Reignier, J | 1 |
| Al-Khayatt, MS; Brull, DJ; Campbell, VL; O'Mahony, C | 1 |
| Collidge, TA; Deighan, CJ; Mann, AC; Nolan, C; Razvi, S; Russell, AJ; Stirling, C; Whittle, M | 1 |
| Clarkson, MR; Conlon, PJ; Leavey, SF; Magee, CN; Medani, SA | 1 |
| Almond, A; Donaldson, K; Isles, C; Robertson, S; Teckchandani, S | 1 |
| Carr, AS; Kearney, S; McCarron, MO; McConville, J | 1 |
| Desplaces, N; Gabignon, C; Le Guyader, N; Lidove, O; Zeller, V; Ziza, JM | 1 |
| McGarity, B; Yuen, SL | 1 |
| Burtenshaw, AJ; Downing, R; Sellors, G | 1 |
| El Menjawi, I; Fladerer, P; Krause, R; Pohanka, E; Wenisch, C | 1 |
| Kirisits, W; Kotanko, P; Skrabal, F | 1 |
1 review(s) available for fusidic acid and Rhabdomyolysis
| Article | Year |
|---|---|
Rhabdomyolysis after co-administration of a statin and fusidic acid: an analysis of the literature and of the WHO database of adverse drug reactions.
Topics: Aged; Anti-Bacterial Agents; Databases, Factual; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Fusidic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Rhabdomyolysis; Time Factors | 2018 |
12 other study(ies) available for fusidic acid and Rhabdomyolysis
| Article | Year |
|---|---|
A timely reminder about the concomitant use of fusidic acid with statins.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Drug Interactions; Drug Therapy, Combination; Fluorobenzenes; Fusidic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Osteoarthritis; Prosthesis-Related Infections; Pyrimidines; Rhabdomyolysis; Rosuvastatin Calcium; Staphylococcal Infections; Sulfonamides | 2013 |
Fatal rhabdomyolysis following the co-prescription of fusidic acid and pravastatin.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Biotransformation; Comorbidity; Cytochrome P-450 Enzyme System; Drug Interactions; Fatal Outcome; Fusidic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Osteitis; Pravastatin; Rhabdomyolysis; Staphylococcal Infections; Tibia | 2015 |
Rhabdomyolysis with atorvastatin and fusidic acid.
Topics: Aged; Anti-Bacterial Agents; Atorvastatin; Drug Interactions; Drug Therapy, Combination; Floxacillin; Fusidic Acid; Heart Diseases; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Osteomyelitis; Pyrroles; Rhabdomyolysis | 2008 |
Severe statin-induced rhabdomyolysis mimicking Guillain-Barré syndrome in four patients with diabetes mellitus treated with fusidic acid.
Topics: Aged; Anti-Bacterial Agents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diagnosis, Differential; Drug Interactions; Female; Fusidic Acid; Guillain-Barre Syndrome; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Rhabdomyolysis; Risk Factors; Time Factors | 2010 |
Severe rhabdomyolysis as a consequence of the interaction of fusidic acid and atorvastatin.
Topics: Aged; Anti-Bacterial Agents; Arthritis, Infectious; Atorvastatin; Drug Interactions; Drug Therapy, Combination; Follow-Up Studies; Fusidic Acid; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Osteomyelitis; Pyrroles; Rhabdomyolysis; Severity of Illness Index | 2010 |
Rhabdomyolysis following co-prescription of fusidic acid and atorvastatin.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Drug Interactions; Fusidic Acid; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrroles; Rhabdomyolysis | 2010 |
Rhabdomyolysis after co-prescription of statin and fusidic acid.
Topics: Aged; Anti-Bacterial Agents; Contraindications; Female; Fusidic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Rhabdomyolysis; Surgical Wound Infection; Treatment Outcome; Urinary Tract Infections | 2012 |
[Rhabdomyolysis following the coprescription of atorvastatin and fusidic acid].
Topics: Aged; Anti-Bacterial Agents; Atorvastatin; Creatine Kinase; Fusidic Acid; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Muscle Weakness; Prosthesis-Related Infections; Pyrroles; Rhabdomyolysis; Staphylococcal Infections | 2013 |
Rhabdomyolysis secondary to interaction of fusidic acid and simvastatin.
Topics: Aged; Anti-Bacterial Agents; Anticholesteremic Agents; Drug Interactions; Fusidic Acid; Humans; Male; Rhabdomyolysis; Simvastatin | 2003 |
Presumed interaction of fusidic acid with simvastatin.
Topics: Anti-Bacterial Agents; Drug Interactions; Fatal Outcome; Fusidic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Rhabdomyolysis; Simvastatin | 2008 |
Acute rhabdomyolysis after atorvastatin and fusidic acid therapy.
Topics: Acute Disease; Aged; Angioplasty, Balloon; Anti-Bacterial Agents; Arterial Occlusive Diseases; Atorvastatin; Drug Therapy, Combination; Fusidic Acid; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Pyrroles; Rhabdomyolysis; Risk Factors; Surgical Wound Infection; Tibial Arteries | 2000 |
Rhabdomyolysis and acute renal graft impairment in a patient treated with simvastatin, tacrolimus, and fusidic acid.
Topics: Acute Disease; Anti-Bacterial Agents; Drug Interactions; Female; Fusidic Acid; Humans; Hypolipidemic Agents; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Rhabdomyolysis; Simvastatin; Tacrolimus; Treatment Failure | 2002 |